These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 37433286)
1. Anti-Severe Acute Respiratory Syndrome Coronavirus 2 IgG Is Present in the Amniotic Fluid of both Infected and Vaccinated Women at Second Trimester of Pregnancy: A Cohort Study. La Fauci L; Cavaliere R; Romeo P; Alibrandi A; Ferlazzo G; D'Anna R; Corrado F Fetal Diagn Ther; 2023; 50(6):415-421. PubMed ID: 37433286 [TBL] [Abstract][Full Text] [Related]
2. Maternal and Cord Anti-SARS-CoV-2-Spike IgG following COVID-19 Vaccination versus Infection during Pregnancy: A Prospective Study, Israel October 2021-March 2022. Abu Shqara R; Frank Wolf M; Mikhail Mustafa S; Sgayer I; Assulyn T; Abu Zraki A; Askhar Majadla N; Rechnizter H; Shehadeh M; Fleisher Sheffer V; Bordeynik-Cohen M; Yakir O; Lowenstein L; Sela E; Edelstein M; Dror AA Am J Perinatol; 2024 May; 41(S 01):e1935-e1943. PubMed ID: 37164317 [TBL] [Abstract][Full Text] [Related]
3. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? Scaggs Huang F J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545 [TBL] [Abstract][Full Text] [Related]
4. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery. Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127 [TBL] [Abstract][Full Text] [Related]
5. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy. Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy. Sabharwal V; Taglauer E; Demos R; Snyder-Cappione J; Shaik-Dasthagirisaheb YB; Parker-Kelleher S; Hunnewell J; Boateng J; Clarke K; Yuen R; Barnett ED; Wachman EM; Yarrington CD Am J Perinatol; 2024 May; 41(S 01):e2970-e2977. PubMed ID: 37774748 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels. Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S Clin Infect Dis; 2022 Aug; 75(1):e603-e610. PubMed ID: 35171998 [TBL] [Abstract][Full Text] [Related]
8. Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study. Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S Clin Microbiol Infect; 2022 Mar; 28(3):419-425. PubMed ID: 34740773 [TBL] [Abstract][Full Text] [Related]
9. Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Vaccination in Pregnancy. Otero S; Miller ES; Sunderraj A; Shanes ED; Sakowicz A; Goldstein JA; Mithal LB Clin Infect Dis; 2023 Jan; 76(2):220-228. PubMed ID: 36348510 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. Edlow AG; Li JZ; Collier AY; Atyeo C; James KE; Boatin AA; Gray KJ; Bordt EA; Shook LL; Yonker LM; Fasano A; Diouf K; Croul N; Devane S; Yockey LJ; Lima R; Shui J; Matute JD; Lerou PH; Akinwunmi BO; Schmidt A; Feldman J; Hauser BM; Caradonna TM; De la Flor D; D'Avino P; Regan J; Corry H; Coxen K; Fajnzylber J; Pepin D; Seaman MS; Barouch DH; Walker BD; Yu XG; Kaimal AJ; Roberts DJ; Alter G JAMA Netw Open; 2020 Dec; 3(12):e2030455. PubMed ID: 33351086 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women. Blakeway H; Amin-Chowdhury Z; Prasad S; Kalafat E; Ismail M; Abdallah FN; Rezvani A; Amirthalingam G; Brown K; Le Doare K; Heath PT; Ladhani SN; Khalil A Ultrasound Obstet Gynecol; 2022 Nov; 60(5):673-680. PubMed ID: 36318630 [TBL] [Abstract][Full Text] [Related]
12. Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy. Colavita F; Oliva A; Bettini A; Antinori A; Girardi E; Castilletti C; Vaia F; Liuzzi G Viruses; 2022 Jul; 14(7):. PubMed ID: 35891572 [TBL] [Abstract][Full Text] [Related]
13. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies. Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280 [TBL] [Abstract][Full Text] [Related]
14. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy. Nir O; Schwartz A; Toussia-Cohen S; Leibovitch L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Lustig Y; Regev-Yochay G; Yinon Y Am J Obstet Gynecol MFM; 2022 Jan; 4(1):100492. PubMed ID: 34547533 [TBL] [Abstract][Full Text] [Related]
15. Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and vaccine antibody prevalence in a multi-ethnic inner-city antenatal population: A cross-sectional surveillance study. Andreeva D; Gill C; Brockbank A; Hejmej J; Conti-Ramsden F; Doores KJ; Seed PT; Poston L; BJOG; 2023 Aug; 130(9):1135-1144. PubMed ID: 37113111 [TBL] [Abstract][Full Text] [Related]
16. Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy. St Clair LA; Eldesouki RE; Sachithanandham J; Yin A; Fall A; Morris CP; Norton JM; Abdullah O; Dhakal S; Barranta C; Golding H; Bersoff-Matcha SJ; Pilgrim-Grayson C; Berhane L; Cox AL; Burd I; Pekosz A; Mostafa HH; Klein EY; Klein SL mSphere; 2024 Mar; 9(3):e0081223. PubMed ID: 38426787 [TBL] [Abstract][Full Text] [Related]
17. Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile. Rubio R; Aguilar R; Bustamante M; Muñoz E; Vázquez-Santiago M; Santano R; Vidal M; Melero NR; Parras D; Serra P; Santamaria P; Carolis C; Izquierdo L; Gómez-Roig MD; Dobaño C; Moncunill G; Mazarico E Front Immunol; 2022; 13():999136. PubMed ID: 36238312 [TBL] [Abstract][Full Text] [Related]